Lobular Breast Cancer Spread Into a Nasal Tumor
This breast cancer diagnosis at a glance
- Stage at diagnosis
- Stage IV
- Subtype
- Invasive Lobular Carcinoma
- Biomarkers
- Metastatic lobular focus: ER 8/8; PR 8/8; HER2-negative; E-cadherin-negative.
- Sex
- Female
- Spread to
- liver; bone; right nasal cavity within an olfactory neuroblastoma
- Treatment
- chemotherapy, surgery, hormone therapy and supportive care
- Outcome
- Care Ongoing
Treatment course, step by step
- Neoadjuvant chemotherapy was completed for bilateral breast cancer.
- Bilateral mastectomy was performed.
- Tamoxifen was taken for five years.
- Capecitabine was started for liver and bone metastases.
- Bisphosphonates were given for bone metastases.
- Endoscopic right nasal polypectomy removed the olfactory neuroblastoma containing metastatic lobular breast carcinoma.
- Capecitabine was restarted after multidisciplinary review.
What happened, in summary
A 66-year-old woman was referred for six months of right-sided nasal blockage and occasional clear discharge. She had previously undergone neoadjuvant chemotherapy and bilateral mastectomy for breast cancer 10 years earlier. Pathology had shown invasive ductal carcinoma in the left breast and invasive lobular carcinoma in the right. She then completed five years of tamoxifen.
Two years after the breast surgery, cancer spread to the liver and bone. She began palliative capecitabine and bisphosphonates, and the metastatic disease remained stable under oncology review. The later nasal symptoms led to CT imaging, which showed a polyp arising from the skull base. An endoscopic right nasal polypectomy was performed.
Pathology revealed two cancers within the same specimen. Most of the polyp was an olfactory neuroblastoma, but small nests of cells inside it represented metastatic lobular breast carcinoma. Those cells were strongly estrogen- and progesterone-receptor positive, HER2-negative, and E-cadherin negative. Review of older imaging suggested that the olfactory neuroblastoma may have been present with little growth for about a decade.
After surgery, the nasal obstruction and reduced sense of smell resolved, and CT and MRI showed no residual local disease. A multidisciplinary team restarted capecitabine, and she continued regular follow-up for metastatic breast cancer.
Where this story comes from
This is a lay summary of an account first published by PMC / PubMed Central. Read the original in full
How we source and attribute stories Accuracy and limitations
Collections this story belongs to
- Stage 4 Breast Cancer 295 stories
- Stage 4 ER Positive Breast Cancer 87 stories
- ER Positive Breast Cancer 242 stories
- Capecitabine for Breast Cancer 43 stories
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer